Literature DB >> 16690205

Human embryonic stem cells as a cellular model for human disorders.

Inbar Friedrich Ben-Nun1, Nissim Benvenisty.   

Abstract

Human embryonic stem cells (HESCs) are pluripotent cell lines derived from the inner cell mass (ICM) of embryos at the blastocyst stage. These cells possess self renewal capacity and differentiation potential to all three embryonic germ layers. These unique characters made HESCs an attractive research tool for studying early human developmental processes as well as a potential therapeutic tool for various human diseases. Here, we focus on HESCs as a cellular model for human disorders. The advantages of such models as well as the various methodologies to achieve HESCs carrying a genetic defect will be discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16690205     DOI: 10.1016/j.mce.2006.03.034

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  13 in total

Review 1.  Embryonic and induced pluripotent stem cells as a model for liver disease.

Authors:  Hiroshi Yagi; Edgar Tafaleng; Masaki Nagaya; Marc C Hansel; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Crit Rev Biomed Eng       Date:  2009

2.  Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres.

Authors:  Lina Ziegler; Sergei Grigoryan; In Hong Yang; Nitish V Thakor; Ronald S Goldstein
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

Review 3.  Cellular models for disease exploring and drug screening.

Authors:  Zhi-Kun Li; Qi Zhou
Journal:  Protein Cell       Date:  2010-05-08       Impact factor: 14.870

4.  Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.

Authors:  Francesco Paolo Di Giorgio; Monica A Carrasco; Michelle C Siao; Tom Maniatis; Kevin Eggan
Journal:  Nat Neurosci       Date:  2007-04-15       Impact factor: 24.884

Review 5.  Present state and future perspectives of using pluripotent stem cells in toxicology research.

Authors:  Anna M Wobus; Peter Löser
Journal:  Arch Toxicol       Date:  2011-01-12       Impact factor: 5.153

Review 6.  Progress toward the clinical application of patient-specific pluripotent stem cells.

Authors:  Evangelos Kiskinis; Kevin Eggan
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

7.  Retrograde axonal transport of VZV: kinetic studies in hESC-derived neurons.

Authors:  Sergei Grigoryan; Paul R Kinchington; In Hong Yang; Anca Selariu; Hua Zhu; Michael Yee; Ronald S Goldstein
Journal:  J Neurovirol       Date:  2012-08-24       Impact factor: 2.643

8.  Establishment and characterization of baboon embryonic stem cell lines: an Old World Primate model for regeneration and transplantation research.

Authors:  Calvin R Simerly; Christopher S Navara; Carlos A Castro; Janet C Turpin; Carrie J Redinger; Jocelyn D Mich-Basso; Ethan S Jacoby; Kevin J Grund; David A McFarland; Stacie L Oliver; Ahmi Ben-Yehudah; Diane L Carlisle; Patricia Frost; Cecilia Penedo; Laura Hewitson; Gerald Schatten
Journal:  Stem Cell Res       Date:  2009-02-21       Impact factor: 2.020

Review 9.  Modeling neurodevelopmental disorders using human pluripotent stem cells.

Authors:  Michael Telias; Dalit Ben-Yosef
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

10.  Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells.

Authors:  Achia Urbach; Nissim Benvenisty
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.